Stockscreener 앱 받기
31.16
0.71%
0.22
시간 외 거래:
31.16
전일 마감가:
$30.94
열려 있는:
$30.83
하루 거래량:
877.89K
Relative Volume:
0.96
시가총액:
$1.62B
수익:
$225.21M
순이익/손실:
$-15.70M
주가수익비율:
-92.03
EPS:
-0.3386
순현금흐름:
$-4.78M
1주 성능:
-1.89%
1개월 성능:
-11.00%
6개월 성능:
+81.16%
1년 성능:
+74.08%
1일 변동 폭
$30.11
$31.61
1주일 범위
$30.11
$34.22
52주 변동 폭
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
31.16 | 1.61B | 225.21M | -15.70M | -4.78M | -0.3386 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Wells Fargo | Overweight |
| 2025-12-01 | 개시 | Mizuho | Outperform |
| 2025-03-17 | 개시 | Lake Street | Buy |
| 2024-07-01 | 개시 | Raymond James | Outperform |
| 2022-11-11 | 재개 | Jefferies | Buy |
| 2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | Guggenheim | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 개시 | Canaccord Genuity | Buy |
| 2018-03-02 | 재확인 | Lake Street | Buy |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 개시 | Jefferies | Buy |
| 2017-11-21 | 재확인 | Lake Street | Buy |
| 2017-07-31 | 개시 | Leerink Partners | Outperform |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 개시 | ROTH Capital | Buy |
| 2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
| 2016-11-07 | 재확인 | Wedbush | Outperform |
| 2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
| 2016-08-04 | 재확인 | Wedbush | Outperform |
| 2014-05-14 | 개시 | Dawson James | Buy |
| 2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
Axogen chief innovation officer DeVinney sells $171k in shares - Investing.com
Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen (AXGN) officer nets shares after RSU vesting and sale - Stock Titan
Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes - Stock Titan
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 earnings call transcript - MSN
Do Options Traders Have Insights on Axogen Stock That We're Unaware Of? - Bitget
Do Options Traders Know Something About Axogen Stock We Don't? - Yahoo Finance
(AXGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position - MarketBeat
ArrowMark Colorado Holdings LLC Buys 332,498 Shares of AxoGen, Inc. $AXGN - MarketBeat
AXGN SEC FilingsAxogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Axogen (AXGN) Valuation After AVANCE BLA Approval And Updated Growth Outlook - simplywall.st
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum - MarketBeat
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - MSN
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights By Investing.com - Investing.com Nigeria
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights - Investing.com
AxoGen Q3 2025 Earnings Preview - MSN
AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+ - MarketBeat
Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st
AxoGen at Leerink Conference: Strategic Growth and Market Expansion By Investing.com - Investing.com Nigeria
AxoGen at Leerink Conference: Strategic Growth and Market Expansion - Investing.com India
Chipmakers Recap: Is Axogen Inc in a bullish channel2026 Analyst Calls & Accurate Entry/Exit Alerts - baoquankhu1.vn
Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN - MarketBeat
(AXGN) Risk Channels and Responsive Allocation - Stock Traders Daily
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption - National Today
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference - MarketBeat
AxoGen, Inc. $AXGN Shares Acquired by First Eagle Investment Management LLC - MarketBeat
AXGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Roubaix Capital LLC Purchases New Position in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings - Stock Titan
Axogen (AXGN) innovation chief reports stock awards and tax-share withholding - Stock Titan
Axogen (NASDAQ: AXGN) EVP reports RSU vesting and tax share withholding - Stock Titan
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Axogen, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Axogen, Inc. Rings the Opening Bell - Nasdaq
Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift - simplywall.st
AxoGen Set to Announce Q4 Earnings on February 24 - Intellectia AI
AXGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
AxoGen (AXGN) Receives a Buy from H.C. Wainwright - The Globe and Mail
Wall Street Zen Downgrades AxoGen (NASDAQ:AXGN) to Buy - MarketBeat
AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings Signal A 22.88% Upside Potential - DirectorsTalk Interviews
Equity awards and tax share withholding for Axogen (NASDAQ: AXGN) CFO - Stock Titan
Axogen (NASDAQ: AXGN) CEO granted 98,000 RSUs vesting through 2030 - Stock Titan
Axogen (AXGN) Valuation Check After FDA Avance Approval And New 2026 Growth Targets - Sahm
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations - Yahoo Finance
AxoGen Posts Strong Growth and Raises Capital With Offering - The Globe and Mail
Citizens reiterates AxoGen stock rating on strong quarterly revenue By Investing.com - Investing.com Nigeria
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 Earnings Call Transcript - Insider Monkey
axogen Q4 2025 slides: 21% revenue surge, stock tumbles on costs - Investing.com India
Citizens reiterates AxoGen stock rating on strong quarterly revenue - Investing.com
Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):